Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Conditions
Interventions
Intervention1: Autologous whole blood injection: 2.5 ml of blood will be drawn from a vein in the cubital fossa with a 20G needle and a 5 ml syringe and the drawn blood will be
immediately (within 2 m
Sponsors
Dr M Christopher
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients in the age group of 14 years and above 2) Both male and female patients 3) Confirmed cases of COVID 19 admitted for treatment in Shifa hospital; COVID positive confirmed by RT-PCR 4) Presence of IgM antibodies through rapid test kit 5) Willing to give consent for the study and take part actively 6) Patients willing to adhere to drugs protocol as per ICMR guidelines/ WHO guidelines 7) In test arm, patients who are accepting to AWB therapy in addition to standard drugs
Exclusion criteria
Exclusion criteria: 1) Children lesser than 14 years of age 2) Presence of IgG antibodies through rapid test kit 3) Patients hypersensitive to blood products or blood transfusion 4) Any Co-morbid conditions 5) Patients who are critically ill are excluded from the study
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Cytokine storm is assessed in both groupsTimepoint: Interleukin assays are assessed from time to time on scientific methods | — |
Primary
| Measure | Time frame |
|---|---|
| RT-PCR test turning negative is the end pointTimepoint: 14days | — |
Countries
India
Contacts
Public ContactDr M Christopher
Shifa Hospitals
Outcome results
None listed